High throughput screening for inhibition of cytochrome p450 metabolism

被引：0

作者：

Crespi, CL ^{[1
]}

Miller, VP ^{[1
]}

Penman, BW ^{[1
]}

机构：

[1] GENTEST Corp, Woburn, MA 01801 USA

来源：

MEDICINAL CHEMISTRY RESEARCH | 1998年 / 8卷 / 7-8期

关键词：

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：457 / 471

页数：15

共 16 条

[1]

BURKE MD, 1983, CHEM-BIOL INTERACT, V45, P243

[2] CHARACTERIZATION OF THE INHIBITION OF P4501A2 BY FURAFYLLINE [J].

CLARKE, SE ;

AYRTON, AD ;

CHENERY, RJ .

XENOBIOTICA, 1994, 24 (06) :517-526

[3] Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450 [J].

Crespi, CL ;

Miller, VP ;

Penman, BW .

ANALYTICAL BIOCHEMISTRY, 1997, 248 (01) :188-190

[4]

CRSPI CL, 1997, DRUG DRUG INTERACTIO, P171

[5]

FDA,, 1997, GUID IND DISTEST I, P1

[6] P450-ENZYMES - INHIBITION MECHANISMS, GENETIC-REGULATION AND EFFECTS OF LIVER-DISEASE [J].

MURRAY, M .

CLINICAL PHARMACOKINETICS, 1992, 23 (02) :132-146

[7]

Obach RS, 1997, DRUG METAB DISPOS, V25, P1359

[8] A POTENTIALLY HAZARDOUS INTERACTION BETWEEN ERYTHROMYCIN AND MIDAZOLAM [J].

OLKKOLA, KT ;

ARANKO, K ;

LUURILA, H ;

HILLER, A ;

SAARNIVAARA, L ;

HIMBERG, JJ ;

NEUVONEN, PJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (03) :298-305

[9] An overview of current cytochrome P450 technology for assessing the safety and efficacy of new materials [J].

Parkinson, A .

TOXICOLOGIC PATHOLOGY, 1996, 24 (01) :45-57

[10]

Rodrigues AD, 1997, DRUG METAB DISPOS, V25, P1097

← 1 2 →